Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
Azacitidine-Venetoclax or Induction Chemotherapy for Acute Myeloid Leukemia.
Journal: The New England journal of medicine
Published: September 02, 2026
Clinical outcomes of combination treatment with FMS-like tyrosine kinase 3 (FLT3) and isocitrate dehydrogenase 1/2 (IDH1/2) inhibitors in patients with acute myeloid leukaemia.
Journal: British journal of haematology
Published: December 08, 2025
Ixazomib in addition to chemotherapy for the treatment of acute myeloid leukemia in older adults.
Journal: Leukemia & lymphoma
Published: March 12, 2025
A phase I clinical trial of lenalidomide combined with bortezomib for acute myeloid leukemia or myelodysplastic syndrome relapsing after allogeneic stem cell transplantation.
Journal: Leukemia research
Published: November 07, 2024
Multicenter Phase I Trial of Ivosidenib as Maintenance Treatment Following Allogeneic Hematopoietic Cell Transplantation for IDH1-Mutated Acute Myeloid Leukemia.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 20, 2023
Ixazomib in addition to chemotherapy for the treatment of acute lymphoblastic leukemia in older adults.
Journal: Leukemia & lymphoma
Published: January 25, 2022
Low-dose dasatinib: when less can be more.
Journal: The Lancet. Haematology
Published: October 29, 2021
Case 33-2021: A 68-Year-Old Man with Painful Mouth Ulcers.
Journal: The New England journal of medicine
Published: October 27, 2021
Arsenic toxicity manifesting as profuse watery diarrhea during induction therapy for acute promyelocytic leukemia.
Journal: Clinical case reports
Published: January 02, 2021
Long: molecular tracking of CML with bilineal inv(16) myeloid and del(9) lymphoid blast crisis and durable response to CD19-directed CAR-T therapy.
Journal: Leukemia
Published: May 30, 2020
Last Updated: 09/26/2026